Ligand validation:2CIZ

MAN: alpha-D-mannopyranose

MAN is a Ligand Of Interest in 2CIZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2CIZ_MAN_A_1308	97%	66%	0.052	0.969	0.63	0.65	-	-	0	0	100%	0.9167
2CIZ_MAN_A_1309	97%	64%	0.064	0.978	0.84	0.52	1	-	0	0	100%	0.9167
2CIZ_MAN_A_1307	69%	66%	0.09	0.904	0.67	0.61	-	-	0	0	100%	0.9167
2CIZ_MAN_A_1313	29%	54%	0.151	0.809	0.59	1.16	-	1	0	0	100%	0.9167
2CIZ_MAN_A_1311	10%	46%	0.228	0.724	0.61	1.49	-	3	0	0	100%	0.9167
2CIZ_MAN_A_1317	7%	51%	0.275	0.725	0.7	1.18	-	1	0	0	100%	0.9167
2CIZ_MAN_A_1312	7%	61%	0.211	0.656	0.51	0.95	-	1	0	0	100%	0.9167
2CIZ_MAN_A_1314	4%	60%	0.311	0.701	0.62	0.89	-	1	0	0	100%	0.9167
2CIZ_MAN_A_1310	3%	64%	0.228	0.581	0.75	0.62	-	-	0	0	100%	0.4583
7RST_MAN_A_304	97%	61%	0.06	0.978	0.65	0.82	-	-	0	0	100%	0.9167
2CIY_MAN_A_739	97%	53%	0.056	0.969	0.74	1.09	-	1	0	0	100%	0.9167
2J18_MAN_A_1309	97%	61%	0.065	0.977	0.64	0.81	-	1	0	0	100%	0.9167
2CIV_MAN_A_1308	95%	62%	0.077	0.983	0.57	0.86	-	-	0	0	100%	0.9167
2CIW_MAN_A_1307	95%	63%	0.066	0.97	0.66	0.73	-	-	0	0	100%	0.9167
1GAI_MAN_A_480	100%	74%	0.043	0.986	0.45	0.53	-	-	0	0	100%	0.9167
5M03_MAN_A_402	99%	59%	0.034	0.989	0.56	0.99	-	-	0	0	92%	0.9167
1GAH_MAN_A_479	99%	76%	0.05	0.989	0.44	0.5	-	-	0	0	100%	0.9167
1BXO_MAN_A_328	99%	39%	0.05	0.985	1.37	1.08	1	1	0	0	100%	0.9167
7LTB_MAN_B_101	99%	58%	0.053	0.985	0.73	0.85	-	1	0	0	100%	0.9167

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.